Clinical Trial Update: The Triglyceride/Glucose Index and SGLT-2 Inhibitors

View source ↗

Summary

A completed clinical trial update examining the triglyceride/glucose index in relation to SGLT-2 inhibitors for metabolic disease and diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• SGLT-2 inhibitors

Snippet

Sponsor: Samsun Education and Research Hospital | Conditions: Metabolic Disease, Diabetes | Status: COMPLETED